Anzol

 Ranitidine Hydrochloride B.P.                                                                                                             

Therapeutic Class:              

 H2- Receptor Antagonist       

Composition:

    Anzol Tablet: Each Anzol tablet contains 150of Ranitidine HCL B.P.

    Anzol Injection: Each ampoule contains 50mg/2ml of Ranitidine HCL B.P.

Description:

Anzol is ranitidine hydrochloride (HCl), USP, a histamine H2-receptor antagonist. Ranitidine HCl is a white to pale yellow, granular substance that is soluble in water. It has a slightly bitter taste and sulfurlike odor.

Indications:

• Anzol Tablets are indicated in Gastric and duodenal ulcers,Gastroesophageal Reflux.

• Anzol Injections are indicated in Acid suppression syndrome, Stress ulcers and Zollinger- Ellison syndrome

Dosage and administration:

    Tablets: 150-600mg /day for 4-8 weeks.

    Injection: 1ampoule 50mg/2ml, single dose or up to QID, via I.M/I.V route.

Presentation:

     Anzol Tablet 150mg: In a Foil strip pack of 10 tablets.

     Anzol Injection 50mg/2ml: In a pack of 5 ampoules